Skip to content

Evaluation of clinical efficacy of different acupuncture courses for chronic insomnia: a randomized controlled trial

Clinical study on dose-effect relationship of different acupuncture courses on chronic insomnia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073711
Enrollment
Unknown
Registered
2023-07-19
Start date
2023-07-19
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic insomnia disorder

Interventions

Treatment group 1:Acupuncture will be administered 3 sessions a week for a total of 4 weeks
Treatment group 2:Acupuncture will be administered 3 sessions a week for a total of 6 weeks
Treatment group 3:Acupuncture will be administered 3 sessions a week for a total of 8 weeks

Sponsors

Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: All of the following conditions must be met for inclusion: 1. Meet the diagnostic criteria for chronic insomnia in ICSD-3; 2. Insomnia Severity Index =10; 3. Gender is not limited, aged 18-70 years; 4. Did not receive any acupuncture-related intervention within one month before inclusion; 5. Able to communicate normally and actively cooperate with treatment; 6. Join the group voluntarily and sign the informed consent.

Exclusion criteria

Exclusion criteria: Patients will be excluded if they met any of the following criteria: 1. Serious diseases such as cardiovascular, cerebrovascular, nervous, digestive and endocrine systems; 2. Patients with major depression, Hamilton Depression Scale > 24 points; 3. Severe neuropsychiatric disorders, such as cognitive impairment, lifelong bipolar disorder, any type of schizophrenia, paranoia, dementia, organic brain dysfunction, etc.; 4. Patients who abuse or rely heavily on psychoactive substances such as antidepressants, central stimulants, analgesics and sedatives, and alcohol; 5. Secondary insomnia caused by other organic diseases; 6. Pregnant or lactating women; 7. Metal allergy; 8. Researchers who are participating in other topics.

Design outcomes

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index, PSQI;Self-Rating Depression Scale, SDS;Self-Rating Anxiety Scale, SAS;Fatigue Severity Scale, FSS;Percentage of patients with ISI < 8;

Primary

MeasureTime frame
Insomnia Severity Index,ISI;

Countries

China

Contacts

Public ContactJie Wu

Chengdu University of Traditional Chinese Medicine

drwujie@163.com+86 189 8188 5750

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 6, 2026